Compliance with guidelines in the surgical management of cutaneous melanoma across the USA

Nabil Wasif, Richard J. Gray, Sanjay P. Bagaria, Barbara A Pockaj

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The National Comprehensive Cancer Network has formulated guidelines for the management of cutaneous malignant melanoma with regard to resection margins (RMs) and regional staging. The aim of this study was to assess compliance with these recommendations in the general population of the USA. The Surveillance, Epidemiology and End-Results database was examined to identify 60 194 patients with malignant melanoma from 2004 to 2008. Multivariate logistic regression analysis was used to identify factors predictive of RM less than 1 cm and noncompliance with sentinel lymph node biopsy (SLNB). The median age of the population was 60 years and the mean Breslow thickness was 1.20±0.16 mm. The majority of patients had a RM of less than 1 cm (58%) and only 53% of eligible patients had undergone SLNB. Regional nodal dissection was performed in 69% of patients with a positive SLNB and in 78% with palpable lymphadenopathy. On multivariate analysis age more than 80 years [odds ratio (OR) 1.3, 95% confidence interval (CI) 1.2-1.4], T1 stage (OR 1.5, 95% CI 1.4-1.6), and head and neck primary (OR 1.4, 95% CI 1.3-1.4) all predicted RM of less than 1 cm. Factors predictive of noncompliance with SLNB recommendations included age more than 60 years (OR 1.6, 95% CI 1.5-1.8), T1 stage (OR 2.0, 95% CI 1.8-2.2), head and neck primary (OR 2.0, 95% CI 1.9-2.2), and RM less than 1 cm (OR 2.1, 95% CI 2.0-2.2). RMs and appropriate SLNB are inadequate in the majority of patients currently being treated for malignant melanoma in the USA. A combination of patient and physician education and perhaps regionalization of melanoma care is needed to improve compliance.

Original languageEnglish (US)
Pages (from-to)276-282
Number of pages7
JournalMelanoma Research
Volume23
Issue number4
DOIs
StatePublished - Aug 2013

Fingerprint

Sentinel Lymph Node Biopsy
Melanoma
Odds Ratio
Guidelines
Confidence Intervals
Skin
Neck
Head
Patient Education
Population
Compliance
Margins of Excision
Dissection
Epidemiology
Multivariate Analysis
Logistic Models
Regression Analysis
Databases
Physicians
Neoplasms

Keywords

  • compliance
  • guidelines
  • margin
  • melanoma
  • sentinel lymph node biopsy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Dermatology

Cite this

Compliance with guidelines in the surgical management of cutaneous melanoma across the USA. / Wasif, Nabil; Gray, Richard J.; Bagaria, Sanjay P.; Pockaj, Barbara A.

In: Melanoma Research, Vol. 23, No. 4, 08.2013, p. 276-282.

Research output: Contribution to journalArticle

@article{728198cc83b44f50a518159e4b86e4ec,
title = "Compliance with guidelines in the surgical management of cutaneous melanoma across the USA",
abstract = "The National Comprehensive Cancer Network has formulated guidelines for the management of cutaneous malignant melanoma with regard to resection margins (RMs) and regional staging. The aim of this study was to assess compliance with these recommendations in the general population of the USA. The Surveillance, Epidemiology and End-Results database was examined to identify 60 194 patients with malignant melanoma from 2004 to 2008. Multivariate logistic regression analysis was used to identify factors predictive of RM less than 1 cm and noncompliance with sentinel lymph node biopsy (SLNB). The median age of the population was 60 years and the mean Breslow thickness was 1.20±0.16 mm. The majority of patients had a RM of less than 1 cm (58{\%}) and only 53{\%} of eligible patients had undergone SLNB. Regional nodal dissection was performed in 69{\%} of patients with a positive SLNB and in 78{\%} with palpable lymphadenopathy. On multivariate analysis age more than 80 years [odds ratio (OR) 1.3, 95{\%} confidence interval (CI) 1.2-1.4], T1 stage (OR 1.5, 95{\%} CI 1.4-1.6), and head and neck primary (OR 1.4, 95{\%} CI 1.3-1.4) all predicted RM of less than 1 cm. Factors predictive of noncompliance with SLNB recommendations included age more than 60 years (OR 1.6, 95{\%} CI 1.5-1.8), T1 stage (OR 2.0, 95{\%} CI 1.8-2.2), head and neck primary (OR 2.0, 95{\%} CI 1.9-2.2), and RM less than 1 cm (OR 2.1, 95{\%} CI 2.0-2.2). RMs and appropriate SLNB are inadequate in the majority of patients currently being treated for malignant melanoma in the USA. A combination of patient and physician education and perhaps regionalization of melanoma care is needed to improve compliance.",
keywords = "compliance, guidelines, margin, melanoma, sentinel lymph node biopsy",
author = "Nabil Wasif and Gray, {Richard J.} and Bagaria, {Sanjay P.} and Pockaj, {Barbara A}",
year = "2013",
month = "8",
doi = "10.1097/CMR.0b013e32836254bd",
language = "English (US)",
volume = "23",
pages = "276--282",
journal = "Melanoma Research",
issn = "0960-8931",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Compliance with guidelines in the surgical management of cutaneous melanoma across the USA

AU - Wasif, Nabil

AU - Gray, Richard J.

AU - Bagaria, Sanjay P.

AU - Pockaj, Barbara A

PY - 2013/8

Y1 - 2013/8

N2 - The National Comprehensive Cancer Network has formulated guidelines for the management of cutaneous malignant melanoma with regard to resection margins (RMs) and regional staging. The aim of this study was to assess compliance with these recommendations in the general population of the USA. The Surveillance, Epidemiology and End-Results database was examined to identify 60 194 patients with malignant melanoma from 2004 to 2008. Multivariate logistic regression analysis was used to identify factors predictive of RM less than 1 cm and noncompliance with sentinel lymph node biopsy (SLNB). The median age of the population was 60 years and the mean Breslow thickness was 1.20±0.16 mm. The majority of patients had a RM of less than 1 cm (58%) and only 53% of eligible patients had undergone SLNB. Regional nodal dissection was performed in 69% of patients with a positive SLNB and in 78% with palpable lymphadenopathy. On multivariate analysis age more than 80 years [odds ratio (OR) 1.3, 95% confidence interval (CI) 1.2-1.4], T1 stage (OR 1.5, 95% CI 1.4-1.6), and head and neck primary (OR 1.4, 95% CI 1.3-1.4) all predicted RM of less than 1 cm. Factors predictive of noncompliance with SLNB recommendations included age more than 60 years (OR 1.6, 95% CI 1.5-1.8), T1 stage (OR 2.0, 95% CI 1.8-2.2), head and neck primary (OR 2.0, 95% CI 1.9-2.2), and RM less than 1 cm (OR 2.1, 95% CI 2.0-2.2). RMs and appropriate SLNB are inadequate in the majority of patients currently being treated for malignant melanoma in the USA. A combination of patient and physician education and perhaps regionalization of melanoma care is needed to improve compliance.

AB - The National Comprehensive Cancer Network has formulated guidelines for the management of cutaneous malignant melanoma with regard to resection margins (RMs) and regional staging. The aim of this study was to assess compliance with these recommendations in the general population of the USA. The Surveillance, Epidemiology and End-Results database was examined to identify 60 194 patients with malignant melanoma from 2004 to 2008. Multivariate logistic regression analysis was used to identify factors predictive of RM less than 1 cm and noncompliance with sentinel lymph node biopsy (SLNB). The median age of the population was 60 years and the mean Breslow thickness was 1.20±0.16 mm. The majority of patients had a RM of less than 1 cm (58%) and only 53% of eligible patients had undergone SLNB. Regional nodal dissection was performed in 69% of patients with a positive SLNB and in 78% with palpable lymphadenopathy. On multivariate analysis age more than 80 years [odds ratio (OR) 1.3, 95% confidence interval (CI) 1.2-1.4], T1 stage (OR 1.5, 95% CI 1.4-1.6), and head and neck primary (OR 1.4, 95% CI 1.3-1.4) all predicted RM of less than 1 cm. Factors predictive of noncompliance with SLNB recommendations included age more than 60 years (OR 1.6, 95% CI 1.5-1.8), T1 stage (OR 2.0, 95% CI 1.8-2.2), head and neck primary (OR 2.0, 95% CI 1.9-2.2), and RM less than 1 cm (OR 2.1, 95% CI 2.0-2.2). RMs and appropriate SLNB are inadequate in the majority of patients currently being treated for malignant melanoma in the USA. A combination of patient and physician education and perhaps regionalization of melanoma care is needed to improve compliance.

KW - compliance

KW - guidelines

KW - margin

KW - melanoma

KW - sentinel lymph node biopsy

UR - http://www.scopus.com/inward/record.url?scp=84879937707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879937707&partnerID=8YFLogxK

U2 - 10.1097/CMR.0b013e32836254bd

DO - 10.1097/CMR.0b013e32836254bd

M3 - Article

C2 - 23695440

AN - SCOPUS:84879937707

VL - 23

SP - 276

EP - 282

JO - Melanoma Research

JF - Melanoma Research

SN - 0960-8931

IS - 4

ER -